Cargando…

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long‐Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study

BACKGROUND: Long‐term use of antiplatelet agents after acute coronary syndrome in diabetic patients is not well known. Here, we describe antiplatelet use and outcomes in such patients enrolled in the EPICOR Asia (Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Shaoyi, Xu, Xiaoming, Li, Yi, Li, Jing, Guan, Mingzi, Wang, Xiaozeng, Jing, Quanmin, Huo, Yong, Han, Yaling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763726/ https://www.ncbi.nlm.nih.gov/pubmed/33164633 http://dx.doi.org/10.1161/JAHA.119.013476

Ejemplares similares

Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia
por: Huo, Yong, et al.
Publicado: (2021)

Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study
por: Zheng, Bo, et al.
Publicado: (2020)

Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study
por: Sawhney, J.P.S., et al.
Publicado: (2019)

Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia
por: Jan, Stephen, et al.
Publicado: (2018)

Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study
por: Ertaş, Fatih Sinan, et al.
Publicado: (2016)

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia
por: Zou, Yanan, et al.
Publicado: (2020)

Evaluation of the EpiCore outbreak verification system
por: Lorthe, Taryn Silver, et al.
Publicado: (2018)

EpiCore: Crowdsourcing Health Professionals to Verify Disease Outbreaks
por: Olsen, Jennifer M.
Publicado: (2017)

Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry
por: Annemans, Lieven, et al.
Publicado: (2016)

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
por: Li, Yi, et al.
Publicado: (2020)

A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
por: Qiu, Miaohan, et al.
Publicado: (2022)

Dietary Glycemic Load and Glycemic Index and Risk of Cerebrovascular Disease in the EPICOR Cohort
por: Sieri, Sabina, et al.
Publicado: (2013)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
por: Numasawa, Yohei, et al.
Publicado: (2020)

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China
por: Han, Xiao-Ning, et al.
Publicado: (2020)

Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success
por: Schopka, Simon, et al.
Publicado: (2010)

Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study
por: Iacoviello, Licia, et al.
Publicado: (2013)

The Association between Educational Level and Cardiovascular and Cerebrovascular Diseases within the EPICOR Study: New Evidence for an Old Inequality Problem
por: Ricceri, Fulvio, et al.
Publicado: (2016)

Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement
por: Han, Yaling
Publicado: (2022)

Chinese expert consensus on antithrombotic management of high‐risk elderly patients with chronic coronary syndrome
por: Zhang, Cuntai, et al.
Publicado: (2023)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

Safety of Left Subclavian Artery Selective Coverage without Revascularization in Thoracic Endovascular Aortic Repair for Type B Aortic Dissections
por: Sun, Mingyu, et al.
Publicado: (2022)

Determination of Optimal Fluoroscopic Angulations for Left Main Coronary Artery Ostial Interventions: 3-Dimensional Computed Tomography Validation
por: Sheng, Yuhe, et al.
Publicado: (2022)

Evidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
por: James, Stefan
Publicado: (2013)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
por: He, Peixun, et al.
Publicado: (2021)

Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Tang, Xiuying, et al.
Publicado: (2015)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Development of antithrombotic nanoconjugate blocking integrin α2β1-collagen interactions
por: Zhang, Chao, et al.
Publicado: (2016)

Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats
por: Deng, Jie, et al.
Publicado: (2015)

Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
por: George, Sudhakar, et al.
Publicado: (2019)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Moustafa, Abdelmoniem, et al.
Publicado: (2019)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
por: Bellettini, Elisa, et al.
Publicado: (2021)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_af0rcpehvijs79oer00cgn4uqb